The Role of Integrated Scientific Advice for the Early Determination of RWE Requirements in HTA and Payer Assessments

Dec 03, 2019

Perspectives on Gene Therapy: Defining and Demonstrating Value to Payers

Nov 27, 2019

2019 MassBio Industry Snapshot

Nov 26, 2019

Pragmatic Randomized Trials: Considerations for Design and Implementation

Nov 20, 2019

Delivering on the Promise of Cell Therapy: Challenges and Trends

Nov 20, 2019

Advanced Analytical Approaches for Accelerated Development of Gene Therapy Products

Nov 14, 2019

Posted by ProtaGene

From Data Chaos to Order & Insight: Creating a Connected Data Ecosystem to Drive Drug Development

Nov 14, 2019

What Do Value Assessments Miss?

Nov 14, 2019

The Evidence Forum – Fall 2019

Nov 07, 2019

SURROGATE ENDPOINTS CREATE POTENTIAL, REQUIRE STATISTICAL VALIDATION

Nov 06, 2019

Posted by IDDI Inc